Work

A Phase II Trial Evaluating Rapid Mid-Treatment Nodal Shrinkage to Select for Adaptive Deescalation in p16+ Oropharyngeal Cancer Patients Undergoing Definitive Chemoradiation

Year: 2023

Type: article

Study design: Clinical Trial

Source: International Journal of Radiation Oncology*Biology*Physics

DOI: 10.1016/j.ijrobp.2023.06.374

Authors: J.K. Kim, M. Tam, J.M. Karp, C. Oh, G. Kim, E. Solomon, C.M. Concert, A.E. Vaezi, Z. Li, T. Tran, E. Zan, P. Corby, M. Feron-Rigodon, C. Del Vecchio Fitz, J.D. Goldberg, T. Hochman, B. Givi, A. Jacobson, M. Persky, K.S. Hu

Institutions: NYU Langone Health, New York University, Cornell University, Weill Cornell Medicine, NYU Langone’s Laura and Isaac Perlmutter Cancer Center, University of Pennsylvania, Memorial Sloan Kettering Cancer Center

Language: English

Topic: Head and Neck Cancer Studies

Subfield: Otorhinolaryngology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4387207992

FWCI: 0.878

Cites:

Cited by: 4

Related to: 10